| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/06/2011 | CN101999990A Anti-caries and antiallergic mouth wash |
| 04/06/2011 | CN101999667A Alkali extraction of mung bean flavone and method for preparing flavone mung bean beverage |
| 04/06/2011 | CN101658643B Medicament for treating allergic purpura |
| 04/06/2011 | CN101628017B Method for preparing oral liquid |
| 04/06/2011 | CN101618056B Great burdock achene Chinese herb soft capsule preparation and preparation method thereof |
| 04/06/2011 | CN101564464B Chinese medicament for adjusting organism immunity of tumor patients |
| 04/06/2011 | CN101536854B Health-caring process quilt |
| 04/06/2011 | CN101530442B Asarum volatile oil prepared by vacuum distillation method and use thereof |
| 04/06/2011 | CN101406545B Rosa roxburghii soft capsule and preparation method thereof |
| 04/06/2011 | CN101406491B Oil-in-water Cordyceps sinensis emulsion and preparation technique |
| 04/06/2011 | CN101302252B Extrasin alphal (Tal) analogue, production process and medical use thereof |
| 04/06/2011 | CN101293894B Preparing intermediate of 2-propylidene-19-nor-vitamin D compounds |
| 04/06/2011 | CN101273999B Jinhuakui products and uses thereof |
| 04/06/2011 | CN101262861B Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 04/06/2011 | CN101195559B Process for producing resveratrol nano-crystallization and uses thereof |
| 04/06/2011 | CN101161233B Ebstine solid oral preparation and its preparing method |
| 04/06/2011 | CN101147779B Composition containing nucleotide, its preparation method and its use |
| 04/06/2011 | CN101095465B Application of low-polyxylose complicated preparation in the preparing of feedstuff that is capable of enhancing immunity of marine animals |
| 04/06/2011 | CN101069743B Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases |
| 04/06/2011 | CN101052411B VLP-antigen conjugates and their uses as vaccines |
| 04/06/2011 | CN101020026B Honeyed Guiqi ointment for enhancing body's resistance and its preparation |
| 04/05/2011 | US7919614 Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2011 | US7919524 Compounds, compositions and methods |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919490 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
| 04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 03/31/2011 | WO2011038186A1 Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof |
| 03/31/2011 | WO2011037467A1 Atazanavir for treating inflammatory diseases |
| 03/31/2011 | WO2011037433A2 Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011035900A1 New thiadiazole derivatives |
| 03/31/2011 | WO2011035855A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 03/31/2011 | WO2011035534A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | WO2011035422A1 Method of preparing plant-derived vlps |
| 03/31/2011 | WO2010132725A3 Cyclin dependent kinase inhibitors and methods of use |
| 03/31/2011 | WO2010117829A3 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome |
| 03/31/2011 | WO2010108187A3 Compounds and methods for treating mammalian gastrointestinal microbial infections |
| 03/31/2011 | WO2010096170A3 Inhibition of trna synthetases and therapeutic applications thereof |
| 03/31/2011 | WO2010085377A3 Hydroxamic acid derivatives |
| 03/31/2011 | WO2010001257A3 Novel solid state forms of laquinimod and its sodium salt |
| 03/31/2011 | US20110077402 Administration of dipeptidyl peptidase inhibitors |
| 03/31/2011 | US20110077299 Inhibitors of alpha4 mediated cell adhesion |
| 03/31/2011 | US20110077296 Method and composition for delivering zinc to the nasal membrane |
| 03/31/2011 | US20110077282 Novel compounds from antrodia camphorata |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077252 Pyridyl derivatives, their preparation and use |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077243 Triazolopyridine Compounds Useful As Kinase Inhibitors |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110077233 C-Met Modulators and Method of Use |
| 03/31/2011 | US20110077232 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug |
| 03/31/2011 | US20110077209 Protein or glycoprotein from haliotis midae and its use as an immunotherapy agent |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077207 Method for treating inflammation |
| 03/31/2011 | US20110077198 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110076348 Prophylactic and/or therapeutic agent for atopic dermatitis |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076331 Use of Deuterium Oxide as an Elastase Inhibitor |
| 03/31/2011 | US20110076323 Vaccine for alzheimer's disease |
| 03/31/2011 | US20110076322 Amphoteric liposomes |
| 03/31/2011 | US20110076305 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 03/31/2011 | US20110076304 Adapter molecule for the delivery of adenovirus vectors |
| 03/31/2011 | US20110076300 Hybrid Polypeptides Including Meningococcal fHBP Sequences |
| 03/31/2011 | US20110076299 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/31/2011 | US20110076297 Peptides for Inducing Heterosubtypic Influenza T Cell Responses |
| 03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 03/31/2011 | US20110076294 Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing |
| 03/31/2011 | US20110076293 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/31/2011 | US20110076278 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders |
| 03/31/2011 | US20110076270 Therapeutic Binding Molecules |
| 03/31/2011 | US20110076258 Methods of modulating t cell- dependent immune responses |
| 03/31/2011 | US20110076233 Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting |
| 03/31/2011 | CA2775475A1 Pyridinylimidazolone derivatives for inhibition of pi3 kinases |
| 03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2774946A1 Identification of antigenic peptides from multiple myeloma cells |
| 03/31/2011 | CA2774731A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | CA2773351A1 Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof |
| 03/31/2011 | CA2772962A1 Method of preparing plant-derived vlps |
| 03/30/2011 | EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301967A2 Single domain antibodies for nasal administration |
| 03/30/2011 | EP2301964A1 High affinity HIV T cell receptors |
| 03/30/2011 | EP2301629A2 Anti-interferon-alpha antibodies |
| 03/30/2011 | EP2301628A1 Methods and reagents for the treatment of immunoinflammatory disorders |
| 03/30/2011 | EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/30/2011 | EP2301579A1 Therapeutic method for reducing angiogenesis |
| 03/30/2011 | EP2301576A1 Therapeutic use of Anti-CS1 Antibodies |
| 03/30/2011 | EP2301570A1 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins |
| 03/30/2011 | EP2301567A1 Selective immune down regulation (SIDR) for transplantation |